 |
MIDWEST BIORESEARCH GROWTH CONTINUES Evanston, Ill. (June 28, 2006) -- Midwest BioResearch, LLC (MBR), founded by former scientists, managers and directors from major pharmaceutical companies to provide outsourced drug disposition and toxicology services, today announced the appointment of Paul Donovan as its Controller and Peggy Tsatsos as manager in the company’s Analytical Operations group. The company now has a staff of more than 30 with proven experience in drug discovery and development. Mr. Donovan will provide financial leadership and business guidance for the rapidly expanding company. He brings more than 25 years of experience in the pharmaceutical industry, including financial and business positions within Pfizer, Pharmacia, Monsanto and G.D. Searle. While with these companies, Mr. Donovan managed multi-million dollar R&D budgets and evaluated internal and external development opportunities. He was a member of numerous development teams including third party collaborations. Mr. Donovan holds a B.S. and M.S. degree in biochemistry and a MBA from Boston University. Dr. Tsatsos will be a manager in the MBR’s fast-growing Small Molecule Bioanalysis group and report to director Jenifer Johnson. Dr. Tsatsos brings more than seven years of bioanalytical experience to MBR. Prior to joining MBR, Dr. Tsatsos worked as a senior scientist for Abbott Laboratories where she led research programs in analyzing and characterizing immunosuppressive drugs, microparticles and prostate and breast cancer product lines. Prior to Abbott, she worked for Argonne National Laboratory standardizing analytical detection techniques for use with microarrays. Dr. Tsatsos holds a Ph.D. in biochemistry from the University of Illinois Urbana-Champaign. “MBR continues to enjoy robust growth, providing proof that there is a growing market for high quality and timely bioanalytical and toxicology specialty services in preclinical and clinical drug development,” said Michael Schlosser, Ph.D., president and founder of MBR. “Paul and Peggy add to our core strength of proven pharmaceutical experience that will help ensure our clients meet aggressive milestones.” About Midwest Bioresearch, LLC. |
